| 000 | 01808 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250513211000.0 | ||
| 264 | 0 | _c20000608 | |
| 008 | 200006s 0 0 eng d | ||
| 022 | _a0360-3016 | ||
| 024 | 7 |
_a10.1016/s0360-3016(00)00457-0 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAref, A | |
| 245 | 0 | 0 |
_aThe influence of beam energy on the outcome of postoperative radiotherapy in head and neck cancer patients: secondary analysis of RTOG 85-03. _h[electronic resource] |
| 260 |
_bInternational journal of radiation oncology, biology, physics _cMay 2000 |
||
| 300 |
_a389-94 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 | _aAnalysis of Variance |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aCarcinoma, Squamous Cell _xdrug therapy |
| 650 | 0 | 4 |
_aCisplatin _xadministration & dosage |
| 650 | 0 | 4 |
_aCobalt Radioisotopes _xtherapeutic use |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFluorouracil _xadministration & dosage |
| 650 | 0 | 4 |
_aHead and Neck Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aRadiopharmaceuticals _xtherapeutic use |
| 650 | 0 | 4 | _aRadiotherapy Dosage |
| 700 | 1 | _aBerkey, B A | |
| 700 | 1 | _aSchwade, J G | |
| 700 | 1 | _aEnsley, J | |
| 700 | 1 | _aSchuller, D E | |
| 700 | 1 | _aHaselow, R E | |
| 700 | 1 | _aErvin, T J | |
| 700 | 1 | _aLaramore, G E | |
| 773 | 0 |
_tInternational journal of radiation oncology, biology, physics _gvol. 47 _gno. 2 _gp. 389-94 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0360-3016(00)00457-0 _zAvailable from publisher's website |
| 999 |
_c10754280 _d10754280 |
||